Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
42.25
+0.76 (1.83%)
At close: Dec 20, 2024, 4:00 PM
42.80
+0.55 (1.30%)
After-hours: Dec 20, 2024, 7:53 PM EST

Viking Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
4.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Integer Holdings 1.71B
Alkermes 1.51B
Tempus AI 640.44M
ADMA Biologics 382.81M
Axsome Therapeutics 338.46M
TG Therapeutics 264.79M
Krystal Biotech 241.52M
BridgeBio Pharma 217.77M
Revenue Rankings